Nuveen Asset Management, LLC Oncocyte Corp Transaction History

Nuveen Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.86 - $1.53 $883,643 - $1.57 Million	-1,027,493 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.15 - $2.25 $309,376 - $605,301	-269,023 Reduced 20.75%	1,027,493 $1.45 Million
Q4 2021 Feb 14, 2022	SELL	$2.04 - $3.59 $228,816 - $402,672	-112,165 Reduced 7.96%	1,296,516 $2.72 Million
Q3 2021 Nov 12, 2021	SELL	$3.53 - $5.89 $188,794 - $315,014	-53,483 Reduced 3.66%	1,408,681 $5.59 Million
Q2 2021 Aug 16, 2021	BUY	$3.77 - $6.0 $1.82 Million - $2.9 Million	483,320 Added 49.38%	1,462,164 $8.39 Million
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $1.76 Million - $4.78 Million	735,909 Added 302.92%	978,844 $5.08 Million
Q4 2020 Feb 16, 2021	BUY	$1.38 - $2.63 $29,799 - $56,792	21,594 Added 9.76%	242,935 $580,000
Q3 2020 Nov 16, 2020	SELL	$1.2 - $1.89 $71,008 - $111,838	-59,174 Reduced 21.09%	221,341 $308,000
Q2 2020 Aug 14, 2020	BUY	$1.91 - $3.45 $370,486 - $669,203	193,972 Added 224.13%	280,515 $536,000
Q1 2020 May 14, 2020	BUY	$1.76 - $3.02 $48,690 - $83,548	27,665 Added 46.99%	86,543 $212,000
Q4 2019 Feb 14, 2020	SELL	$1.51 - $2.27 $12,107 - $18,200	-8,018 Reduced 11.99%	58,878 $132,000
Q3 2019 Nov 14, 2019	SELL	$1.59 - $2.51 $50,563 - $79,820	-31,801 Reduced 32.22%	66,896 $141,000
Q2 2019 Aug 15, 2019	BUY	$2.49 - $5.45 $245,755 - $537,898	98,697 New	98,697 $246,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $256M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.